SCHEMBL19081431

SCHEMBL19081431

c1ccc(-c2c3ccccc3c(-c3cc4c5cc6ccccc6cc5oc4c4oc5ccccc5c34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.38
ESR2 Q92731 5/20 0.38
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 3/20 0.35
CASP7 P55210 2/20 0.35
TSHR P16473 2/20 0.35
ADORA2A P29274 1/20 0.35
CDC14B O60729 1/20 0.35
CDC14A Q9UNH5 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
KMT2A Q03164 3/20 0.34
GAA P10253 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
MEN1 O00255 2/20 0.34
CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081636 0.90 ESR1 (0.35) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL17945030 0.89 AHR (0.41) ESR2KDM4EHSD17B10MAPTHPGD
SCHEMBL17944581 0.87 ALOX5 (0.40) ESR2KDM4EHSD17B10MAPTHPGD
SCHEMBL23918970 0.85 ESR1 (0.43) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL26404285 0.85 ALOX5 (0.44) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL19081615 0.84 ESR1 (0.36) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL17945581 0.84 PGR (0.37) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL17944087 0.83 ALOX5 (0.37) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL19081436 0.83 ESR1 (0.39) ESR1ESR2KDM4EHSD17B10MAPT
SCHEMBL24614747 0.83 ESR1 (0.39) ESR1ESR2KDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885KDM4E 3720/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885KDM4E 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.